# Systemic Lupus Erythematosus-Associated Myelitis Mimicking Spinal Glioblastoma: A Case Report

**Authors:** Yuki Sakaeyama, Shuhei Kubota, Hiroshi Takahashi, Eisuke Tanaka, Nobuo Sugo

PMC · DOI: 10.7759/cureus.102763 · Cureus · 2026-02-01

## TL;DR

A case of lupus-related spinal inflammation was mistaken for a tumor, but improved with steroid treatment, avoiding surgery.

## Contribution

Highlights SLE-associated myelitis mimicking spinal glioblastoma and the importance of steroid responsiveness in diagnosis.

## Key findings

- MRI features of SLE-associated myelitis can resemble spinal glioblastoma.
- Prompt glucocorticoid therapy led to rapid neurological improvement and lesion reduction.
- Short-interval follow-up imaging helped avoid unnecessary surgery.

## Abstract

Systemic lupus erythematosus (SLE)-associated myelitis is an uncommon but potentially disabling neurological manifestation that can present with radiological features resembling other intramedullary spinal cord disorders. Imaging findings may overlap with demyelinating diseases or intramedullary tumors such as spinal glioblastoma, which can lead to diagnostic uncertainty and consideration of invasive procedures. Early recognition is important because prompt initiation of glucocorticoid (GC) and immunosuppressive therapy may result in neurological improvement.

A 48-year-old woman with a long-standing history of SLE presented with progressive numbness and mild weakness of the lower extremities. Spinal MRI demonstrated an intramedullary lesion at the Th1-2 level with T2 hyperintensity and heterogeneous gadolinium enhancement, initially raising suspicion for spinal glioblastoma. Cerebrospinal fluid analysis revealed mild pleocytosis without oligoclonal bands, and both aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies were negative. Given the possibility of inflammatory myelitis, GC therapy was initiated. Her sensory symptoms improved within several days, and a follow-up MRI performed one week later showed a marked reduction in lesion size and contrast enhancement. Surgical intervention was therefore deferred. The patient has remained relapse-free for 20 months under a gradual GC taper.

This case demonstrates that SLE-associated myelitis can closely mimic spinal glioblastoma on MRI. Responsiveness to GC therapy and short-interval follow-up imaging can provide important diagnostic clues and help avoid unnecessary surgical procedures. Autoimmune myelitis should be considered in the differential diagnosis of intramedullary spinal cord lesions.

## Linked entities

- **Proteins:** AQP4 (aquaporin 4)
- **Chemicals:** gadolinium (PubChem CID 23982)
- **Diseases:** Systemic lupus erythematosus (MONDO:0007915)

## Full-text entities

- **Genes:** SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, AQP4 (aquaporin 4) [NCBI Gene 361] {aka MIWC, MLC4, WCH4, hAQP4}, MOG (myelin oligodendrocyte glycoprotein) [NCBI Gene 4340] {aka BTN6, BTNL11, MOGIG2, NRCLP7}, GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}
- **Diseases:** arthritis (MESH:D001168), metastases (MESH:D009362), cytopenias (MESH:D006402), ataxia (MESH:D001259), demyelinating disease (MESH:D003711), encephalitis (MESH:D004660), infection (MESH:D007239), Spinal intramedullary lesions (MESH:D013120), hypoesthesia (MESH:D006987), pleocytosis (MESH:D007964), lymphoma (MESH:D008223), multiple sclerosis (MESH:D009103), NMOSD (MESH:D009471), necrotic (MESH:D009336), Spinal Glioblastoma (MESH:D005909), neurological deterioration (MESH:D009422), inflammatory (MESH:D007249), inflammatory demyelination (MESH:D020277), GC (MESH:C564221), spinal glioma (MESH:D005910), neuropsychiatric SLE (MESH:D020945), malignancy (MESH:D009369), motor weakness (MESH:D018908), sensory disturbance (MESH:D012678), cord swelling (MESH:D004487), sphincter dysfunction (MESH:D046628), meningitis (MESH:D008580), leukopenia (MESH:D007970), rash (MESH:D005076), Autoimmune myelitis (MESH:D009187), autoimmune disorder (MESH:D001327), dysarthria (MESH:D004401), neurological decline (MESH:D009461), spinal lesions (MESH:D013122), spinal cord lesions (MESH:D013118), SLE (MESH:D008180)
- **Chemicals:** Dexamethasone (MESH:D003907), Gadolinium (MESH:D005682), steroid (MESH:D013256), glucose (MESH:D005947), Fat (MESH:D005223)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12955296/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12955296/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC12955296/full.md

---
Source: https://tomesphere.com/paper/PMC12955296